Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS)
- Resource Type
- Article
- Authors
- Jia, Weiping; Ma, Jianhua; Miao, Heng; Wang, Changjiang; Wang, Xiaoyue; Li, Quanmin; Lu, Weiping; Yang, Jialin; Zhang, Lihui; Yang, Jinkui; Wang, Guixia; Zhang, Xiuzhen; Zhang, Min; Sun, Li; Yu, Xuefeng; Du, Jianling; Shi, Bingyin; Xiao, Changqing; Zhu, Dalong; Liu, Hong; Zhong, Liyong; Xu, Chun; Xu, Qi; Liang, Ganxiong; Zhang, Ying; Li, Guangwei; Gu, Mingyu; Liu, Jun; Yuan, Guoyue; Yan, Zhaoli; Yan, Dewen; Ye, Shandong; Zhang, Fan; Ning, Zhiqiang; Cao, Haixiang; Pan, Desi; Yao, He; Lu, Xianping; Ji, Linong
- Source
- In Science Bulletin 15 August 2021 66(15):1581-1590
- Subject
- Language
- ISSN
- 2095-9273